In pediatric epiglottitis/croup, what is the nebulized epinephrine dose?

In pediatric epiglottitis/croup, what is the nebulized epinephrine dose?

• A. 0.3 ml Nebulized epinephrine
• B. 3 ml Nebulized epinephrine (3 mg)
• C. 10 ml Nebulized epinephrine
• D. 1 ml Nebulized epinephrine

Answer: (B)

Nebulized epinephrine is used in pediatric croup and epiglottitis to rapidly reduce airway mucosal edema through vasoconstriction, which helps to open the airway quickly. The standard single-dose approach is to give a total nebulized volume of 3 mL. This is typically achieved by delivering a small amount of racemic epinephrine (commonly 0.5 mL of a concentrated solution) and diluting it to reach a final volume of 3 mL for the nebulizer. The goal is a quick onset of relief (often within 10–30 minutes) with effects that last about a couple of hours, so the patient remains under observation for potential rebound symptoms. That’s why the 3 mL total nebulized dose is the best choice: it reflects the established single-dose regimen used in practice and in many guidelines. Other options that propose markedly different volumes don’t align with the standard single-dose approach and wouldn’t provide the typical rapid, clinically meaningful improvement in airway edema after a single administration. After administration, monitor for side effects such as tachycardia or hypertension, and be prepared for potential repeat dosing if symptoms persist.

Nebulized epinephrine is used in pediatric croup and epiglottitis to rapidly reduce airway mucosal edema through vasoconstriction, which helps to open the airway quickly. The standard single-dose approach is to give a total nebulized volume of 3 mL. This is typically achieved by delivering a small amount of racemic epinephrine (commonly 0.5 mL of a concentrated solution) and diluting it to reach a final volume of 3 mL for the nebulizer. The goal is a quick onset of relief (often within 10–30 minutes) with effects that last about a couple of hours, so the patient remains under observation for potential rebound symptoms.

That’s why the 3 mL total nebulized dose is the best choice: it reflects the established single-dose regimen used in practice and in many guidelines. Other options that propose markedly different volumes don’t align with the standard single-dose approach and wouldn’t provide the typical rapid, clinically meaningful improvement in airway edema after a single administration. After administration, monitor for side effects such as tachycardia or hypertension, and be prepared for potential repeat dosing if symptoms persist.